Gufeng Gao
Overview
Explore the profile of Gufeng Gao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
18
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cai K, Lin S, Gao G, Sagor M, Luo Y, Chen Z, et al.
Sci Rep
. 2024 Nov;
14(1):26385.
PMID: 39487252
Septic cardiomyopathy (SCM), a complication initiated by sepsis, presents a significant clinical challenge, leading to increased mortality rates. However, the mechanisms of SCM have not been fully uncovered. Our study...
2.
Chen W, Chen A, Lian G, Yan Y, Liu J, Wu J, et al.
J Mol Cell Cardiol
. 2024 Jul;
195:24-35.
PMID: 39002608
Pulmonary hypertension (PH) is characterized by excessive proliferation and migration of pulmonary arterial smooth muscle cells (PASMCs), in which inflammatory signaling caused by activation of the NF-κB pathway plays an...
3.
Chen X, Yu X, Lian G, Tang H, Yan Y, Gao G, et al.
Biomed Pharmacother
. 2024 Apr;
174:116505.
PMID: 38574614
Pulmonary arterial hypertension (PAH) was a devastating disease characterized by artery remodeling, ultimately resulting in right heart failure. The aim of this study was to investigate the effects of canagliflozin...
4.
Chen Y, Chen C, Gao G, Zeng C, Chen Z, Lin G, et al.
Front Genet
. 2023 Nov;
14:1292164.
PMID: 38028627
Laryngeal cancer (LC), a highly fatal tumor in the head and neck region, has been the focus of research in recent years. The study of LC has primarily focused on...
5.
Gao G, Chen A, Gong J, Lin W, Wu W, Mohammad Ismail Hajary S, et al.
Front Genet
. 2023 Sep;
14:1222368.
PMID: 37732317
Idiopathic pulmonary arterial hypertension (IPAH) is a life-threatening disease with a poor prognosis and high heritability, characterized by elevated pulmonary vascular resistance (PVR) and pulmonary artery pressure. N6-methyladenosine (m6A) RNA...
6.
Lian G, You J, Lin W, Gao G, Xu C, Wang H, et al.
BMC Pulm Med
. 2023 Aug;
23(1):300.
PMID: 37582718
Background: Pulmonary arterial hypertension (PAH) is a pathophysiological syndrome, characterized by pulmonary vascular remodeling. Immunity and inflammation are progressively recognized properties of PAH, which are crucial for the initiation and...
7.
Chen A, Gao G, Lian G, Gong J, Luo L, Liu J, et al.
Cell Cycle
. 2023 May;
22(10):1284-1301.
PMID: 37128643
Metal responsive transcription factor 1 (MTF-1) is a zinc-dependent transcription factor involved in the development of pulmonary arterial hypertension (PAH), which is a life-threatening disease characterized by elevated pulmonary artery...
8.
Gong J, Han Y, Gao G, Chen A, Fang Z, Lin D, et al.
J Clin Hypertens (Greenwich)
. 2023 Feb;
25(3):286-294.
PMID: 36815754
Obesity and overweight are closely related to cardiovascular mortality. Arterial stiffness is one of the important risks for cardiovascular diseases and is strongly related with the cardiovascular mortality. However, the...
9.
Luo L, Wu J, Lin T, Lian G, Wang H, Gao G, et al.
Aging (Albany NY)
. 2021 Apr;
13(8):11954-11968.
PMID: 33886502
Background: Metabonomics has been widely used to analyze the initiation, progress, and development of diseases. However, application of metabonomics to explore the mechanism of pulmonary arterial hypertension (PAH) are poorly...